Savara SVRA
NASDAQ SVRA
$4.99 +0.07 (+1.42%)
At close: Nov 11, 2026 · 4:00 PM EST

Savara (SVRA) Other Non-Current Liabilities (2011 - 2026)

Updated

Analysis

Savara (SVRA) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Savara 1.09 Bn 407.27 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.21 Mn
Jun 30, 2026 770,000.00
Mar 31, 2025 44,000.00
Dec 31, 2024 87,000.00
Sep 30, 2024 128,000.00
Jun 30, 2024 169,000.00
Mar 31, 2024 208,000.00
Dec 31, 2023 247,000.00
Sep 30, 2023 284,000.00
Jun 30, 2023 20,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 54,000.00
Sep 30, 2022 71,000.00
Jun 30, 2022 87,000.00
Mar 31, 2022 102,000.00
Dec 31, 2021 117,000.00
Sep 30, 2021 34,000.00
Jun 30, 2021 35,000.00
Mar 31, 2021 58,000.00
Dec 31, 2020 84,000.00
API Access

Savara Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SVRA&period=max&api_key=YOUR_API_KEY